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ASSESSMENT OF CARDIAC FUNCTION IN LCAD DEFICIENT MICE AFTER A SINGLE BOUT OF ENDURANCE 
EXERCISE 
By Evan M. Lord 
Department of Health Science, Kinesiology, Recreation and Dance 
Faculty Mentor: Charles E. Riggs 
Department of Health Science, Kinesiology, Recreation and Dance 
Abstract 
Fa tty acids are the primary fuel source for cardiac tissue 
in both humans and animals. These become especially im-
portant during times of starvation and long bouts of exercise. 
Fatty acids are broken down into smaller, useable acyl-CoA 
subunits through a process called beta-oxidation. The first 
step in this process must be catalyzed by one of four acyl-CoA 
dehydrogenase enzymes depending on the length of the fatty 
acid to be metabolized. The enzyme that catalyzes the break-
down oflong-chainfatty acids, long-chain acyl-CoA dehydro-
genase (LCAD), was examined. The objective of this study was 
to determine how a single bout of endurance exercise impacts 
cardiac function in LCAD deficient mice as well as to assess 
whether recovery from exercise is adversely affected. Mice 
were separated into four groups for testing: LCAD, non-exer-
cised; LCAD, exercised; control, non-exercised; and control, 
exercised. Mice were exercised by forced running at a speed 
of 31m/min with increasing grade (2%) each 20 min. Twenty-
four hours post-exercise, the mice were anesthetized with 
sodium pentobarbital (40 ml/kg body weight,) and ejection 
fraction, fractional shortening, and cardiac output values were 
determined in both groups. It was determined that exercise had 
no effect on cardiac function or recovery in either the LCAD 
or control group. There was, however, a significant difference 
between the LCAD and control group for fractional shortening 
(p<0.05) and cardiac output (p<0.05). It was concluded that a 
single bout of endurance exercise had no significant effect on 
the cardiac fimction of LCAD dificient mice during recovery, 
although the disease did negatively affect cardiac function 
when compared to the control group. 
Introduction 
In order to perform its numerous tasks, the body must 
constantly produce useable energy from chemical compounds 
such as carbohydrates, proteins, and fats. Fats, specifically 
fatty acids, are stored as triglycerides in both adipose tissue 
~nd skeletal muscle until they are needed for energy produc-
tiOn. The energy stored in these compounds is released through 
a process known as beta-oxidation (Schulz, 1991). Because 
the body depends on numerous sources of fuel, including fats, 
to supply it with energy, beta-oxidation plays a key role in the 
regulation and maintenance of metabolic homeostasis in the 
body. Fatty acid degradation in the mitochondria is an essential 
process for energy production during periods of fasting and 
other metabolic stresses. 
Fatty acids broken down through beta-oxidation pro-
duce adenosine triphosphate (ATP) that is used by the body to 
maintain physiologic function, particularly in cardiac tissue 
and skeletal muscle. ATP produced via oxidation of fatty acids 
is primarily depleted by these tissues during times of prolonged 
exercise and also plays a major role in supplying energy while 
the body is at rest (Coyle, Jeukendrup, Wagenmakers and Saris 
1997). The ATP produced from fatty acids via beta-oxidation, 
the Krebs cycle, and electron transport may also fuel the body 
in times of fasting in order to help regulate the body's blood 
glucose levels since glucose, a molecule that can be oxidized to 
produce ATP, is no longer being supplied by the diet (Schulz, 
1991). 
Within the last thirty years, people have begun to be 
diagnosed with deficiencies of ACDs and other enzymes that 
affect fatty acid metabolism (Ventura, Ruiter, Ijlst, Tacares de 
Almeida, and Wanders, 1998). Although cases offatty acid 
oxidation disorders (FODs) are rare when compared with other 
metabolic diseases, the effects ofthese disorders can be very 
severe and are often fatal in younger patients. FODs are now 
known to be among the most common of genetically inherited 
metabolic disorders and frequently present the individual with 
life-threatening conditions. While more information is being 
uncovered about FODs, there is still much that is unknown 
about them due to their rare occurrence in humans. 
The presence of an LCAD deficiency in mice produces 
symptoms that are most closely associated with those seen in 
humans with a VLCAD deficiency (Kurtz et al. 1998a). Char-
acteristics ofLCAD deficiency in mice may include sudden 
death, fasting and cold intolerance, hypoketotic-hypoglycemia, 
and an increase in the fatty content of the liver and heart. 
Furthermore, LCAD deficiency may be a cause of skeletal 
myopathy in matured mice as well. Exercise has been hypoth-
esized to play a part in the causation or stimulation of all the 
symptoms mentioned above (Strauss et al., 1995; Mathur et al., 
1999). LCAD deficient mice also experience excessive gesta-
tional loss of both LCAD -/- (40%) and LCAD +/-(50%) pups. 
While much is known about LCAD deficiency in humans and 
mice, there are relatively few published studies. 
While use of mice with LCAD deficiency is common, a 
human case of the deficiency has yet to be found. This may be 
due to an increased risk of gestational loss as seen in the mouse 
model (Schuler & Wood et al. 2002). One of the most common 
FAO disorders found in humans is that associated with very-
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long chain fatty acids (VLCAD). Symptoms associated with 
human VLCAD deficiency during infancy include nonketotic 
hypoglycemic coma, cardiac hypertrophy, endocardial fi-
broelastosis, hepatomelagy, Reye-like syndrome, sudden infant 
death syndrome (SIDS), and lipid storage myopathy (Hale 
& Bennett, 1992). While VLCAD deficiencies are the most 
prominent and easily diagnosed type seen in humans, onset of 
the disorder during adolescence or early adulthood is still very 
difficult to detect. Mouse models ofFOD have introduced the 
opportunity to investigate the physiological effects of these 
deficiencies in humans and may potentially lead to earlier and 
easier detection. LCAD deficient mice have become a valuable 
model in the study of triglyceride deposition in both the human 
and animal heart. 
When the oxidation of long-chain fatty acids is impaired, 
both cardiac and muscle tissues can be severely affected (Olgil-
vie et al., I 994). There are five studies suggesting that exercise 
may amplify VLCAD deficiency in humans (Olgilvie et al., 
1994; Strausberg et al., 1997; Smelt et al., 1998; Minetti et al., 
1998; Merinero et al., 1999). Importantly, the patients in the 
above studies represented a variety of ages and all complained 
of abnormal muscle pain and weakness during exercise. 
Further, evidence from previous experiments indicates that 
VLCAD deficiency in mice may cause a delay in the recov-
ery of skeletal muscle from exercise. It is unclear whether the 
delay is associated with a reduced ability to resynthesize ATP 
and phosphocreatine (energy sources), or the reduced ability to 
resynthesize muscle glycogen (carbohydrate) stores. It is also 
unknown whether or not the delayed recovery is associated 
with either rhabdomyolysis or prolonged fatigue. On the whole, 
little is known about how exercise affects skeletal muscle and 
cardiac function in animals with LCAD deficiency. 
Another area of interest is whether FOD disorders specifi-
cally have an effect on the ejection fraction and fractional 
shortening capabilities of the heart. The ejection fraction 
measures the percentage of volume of blood that is ejected with 
each ventricular contraction. Ejection fraction is calculated 
using a ratio that compares the volumes of the left ventricle 
during both systole and diastole (LVdiastole-LVsystole/LVdias-
tole). 
Fractional shortening is another measurement that can be 
used to assess left ventricular performance. Like the ejection 
fraction, fractional shortening measures the efficiency of the 
left ventricle. Instead of using volumes, fractional shortening is 
based on the change in the diameter of the left ventricle during 
systole and diastole (LVdiastole-LVsystole!LVdiastole). This 
method focuses less on volume change and more on cardiac 
tissue function during both systole and diastole. A heart that is 
not functioning properly, therefore, would be expected to pro-
duce a lower fractional shortening percentage than a normally 
functioning heart. In the mouse model, the average value for 
fractional shortening is approximately 57% with values below 
40% being indicative of cardiac malfunction or improper left 
ventricle performance (Gardin et al. 1995). When extrapolated, 
the results produced by the mouse model provide a positive 
correlation with the average known values of the human model. 
It was anticipated that the values obtained for ejection 
fraction, fractional shortening, and cardiac output ofLCAD 
deficient mice would be lower than those seen in wild type con-
trols both during rest and after periods of endurance exercise 
due to their inability to properly use long-chain fatty acids to 
provide energy to the heart during these times. 
Objective 
The objective of this research was to determine if recovery 
from endurance exercise is delayed in LCAD deficient mice 
and if cardiac function is adversely affected. The effects of 
LCAD deficiency and acute exercise on cardiac function were 
assessed by examining specific cardiac dimensions, the ejection 
fraction, fractional shortening, and cardiac output. 
Materials and Methods 
Procedures used in this study were based on the protocol 
reported by Johnson and Riggs (2002). Cardiac function was 
assessed via echocardiography in normal (129 SvJ.C57BL6) 
mice (n=lO) and mice (129 SvC57BL6 knockout) homozy-
gous for an LCAD deficiency (n=IO). All procedures were 
identical for each group of enzyme deficient mice (pre- and 
post-exercise) as well as each control group (pre- and post-
exercise). Mice were divided into four groups: I) non-deficient, 
non-exercised; 2) enzyme deficient, non-exercised; 3) non-
deficient, exercised; 4) enzyme deficient, exercised. Mice were 
exercised by forced running at 31 rnlmin with increasing grade 
(2%) each 20 min. Exercise was terminated upon exhaustion. 
Twenty-four hours post-exercise the mice were anesthetized 
and cardiac function was determined via echocardiographic 
methods. In vivo testing of the contractile properties ofthe 
heart was conducted using echocardiography after anesthetiz-
ing the mouse using sodium pentobarbital ( 40 mg/kg body 
weight) administered interperitoneally. Data were collected 
before and after exercise in LCAD and control mice and the 
results were compared both within groups and between groups. 
The echocardiographic methods used to evaluate cardiac func-
tion provided results consistent to those previously reported by 
Rottman et al. (2003). Stroke volume was determined by trac-
ing the outline of the left ventricle during systole and diastole. 
Measurements were taken for both short- and long-axis views. 
Heart rate was determined by placing needle electrodes in the 
right and left shoulder of the mouse as well as a ground wire in 
the leg. The highest registered reading was used in the com-
putat_ion ~f cardiac output. Cardiac output was determined by 
mult!plymg the value obtained for stroke volume by the value 
obtained for heart rate (CO= SV X HR). " 
Statistical Analysis 
Data were analyzed utilizing analysis of variance (ANO-
VA) procedures in a 2 x 2 factorial design. The factors were 
enzyme deficiency (LCAD deficient, Control) and exercise 
(Exercised, Non-exercised). All comparisons were made at the 
p<0.05 level of significance. 
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Results 
Complete data were collected for n = .I 0 mice in both the 
LCAD and control groups for all variables (EF. FS, SV, HR, 
CO). 
Tab!< I 
Ec.hocardiograph1c Measurements for LCAD Oefident Mice Pre-Exerose 
C.t~ ..... Units ... ., so """'"'m Mulmum EtKt)on Fraatol'l Ef O.ll64 0.1>18 0.750 LOOO 
fractJonal ShOI'lenina F5" 61 1.79 58.1 63.6 
Stro{e Volume w ml cos 000483 0.04 0.05 
Heart fbte HR bpm 370.4 ll.85 340 410 
Cardiac: Output co ml/rmn 11.32 !.lAO 15.08 !8.90 
Echocan:hograph•c Measurements for LCAD Defideot Mice Post-Exerase 
t.atecor; Name Unfts Mtan SO Minimum M~utimtJm 
Ej«bon FriKtlon EF 0.855 0.104 0.750 1.000 
Fracttonal Stu)(tenlna F5~ 60 9 2.91 57.1 65.6 
Stroll:e Volurne SV ml 0.05 0.00483 0.04 0 OS 
Heart Rate HR bJ)m 369 3 17.06 334 415 
(ar(iiiJC OUtput CO mVmm 17.24 0.860 16.00 18.35 
EchocardiOgfaphic Measurement5 for Control Mke Pre-&ercis.e 
Ejec:tloo Fr.KtJon £F 0.870 0.148 0.750 
Fr.cnonar Shoneruna FS" 65.8 2.21 62.2 
Strolto Volume W mL 0.05 0.00183 0.05 
Heart Rat!!! HR bpm 36l0 Pl13 31.5 
Cardiac Output co mVmm 19.04 1.267 17.25 
EchocardlographiC Measurements for Control Mrc.e Post-Exercise 
Ciltecory ~nw Units Me~n SO Minimum 
EtecbM ftiKtJon EF 0 .888 C 099 0.750 
frac:bOnal Shcxtenllli FS" &l.J 2..52 61.2 
Stroke Volume SV ml 0.05 0 00421 0.05 
Heart Rite hR b-pm 369 3 27116 llC 
UrdliC Outpla co ml/min 18.95 0.889 17.50 
Mulmum 
1.000 
69.0 
0.06 
408 
21.36 
1.000 
68.6 
0.06 
405 
20.25 
Ejection Fraction 
Ejection fraction values were determined before and after 
exercise for both experimental groups. The average value of 
ejection fraction for the LCAD group before exercise was 
found to be 0.864 ± 0.098 and the average EF after exercise in 
the same population was 0.855 ± 0.1 04. Average values of ejec-
tion fraction were also obtained for the control group before 
and after exercise. These values were found to be 0.870 ± 0.148 
and 0.888 ± 0.099, respectively. 
There was no significant difference between the values 
obtained for either group as a result of exercise. There was 
also no significant difference between the LCAD and control 
groups. 
Fractional Shortening 
Values for fractional shortening were obtained before and 
after exercise for both experimental groups. Averages were 
determined for all groups and are included in Table 1. The av-
erage value of FS for the LCAD group before ex ere ise was 61 ± 
I. 79 and the average value after exercise was 60.9 ± 2.91 . Data 
were also compiled and averaged for the control group which 
produced re ults of65.8 ± __ 21 (%) and 64.3 ± 2.52 (%) before 
and after exercise respectively. 
There was no significant difference in fractional shorten-
ing as a result of exercise. There was, however, a significant 
difference present between the average value obtained for the 
LCAD and control groups (p<0.05). A graphical interpretation 
of the results can be seen in Figure l beiO\ . 
FS Averages in Control and LCAD Mice 
.. 
c: 
c 65.00% ~ 
0 
.c 
"' 60.00% 
.. 
c: 
~ 55.00% 
~ 
50.00% 
• Pri!'-E.t<erctse 
• Post ·exerose 
Control LCAO 
Figure I: A significant difference was presem berweenthe comrol and LCA D 
groups both pre- (p = 0.001) 011d post-exercise (p = 0.0/3). 
Cardiac Output 
Cardiac output values were determined for both LCAD 
and control groups before and after exercise. The average 
values for cardiac output for the LCAD group were found to be 
17.32 ± 1.146 (ml!min) before exercise and 17.24 ±0.860 (ml! 
min) after exercise. The control group produced averages of 
19.04 ± 1.267 and 18.95 ± 0.889 for the pre- and post-exerci e 
groups, respectively. While no significant difference was 
found as a result of exercise, there was a significant differ-
ence between the LCAD and control groups (p<O.OS). Figure 2 
shows the mean values of cardiac output ofboth the LCAD and 
control mice before and after exercise. 
Discussion 
CO Averages for Control and LCAO Mice 
c l 20.00 ---==t:===-------::--
!. 15.00 
:; 
; 10.00 
0 
~ s.oo 
'E ~ 0.00 
Control LCAO 
• Pre-exercise 
• Past-e.xerc1se 
Fig~~re 1: A signijic011t difference was present between the control 011d LCAD groups 
both pre· (p = 0.005) 011d post-exercise (p = 0.001). 
Variation of data was seen within individuals in both 
groups and across all variables. Discrepancy in the data pro-
duced for each individual can largely be attributed to the natu-
ral variation in homeostatic conditions commonly een in both 
humans and animals. It i also possible that the condition of the 
mouse (stress level/activity level) at the time of testing had an 
· impact on cardiac function . However. it i likely that an~ s~ch 
effect was minimal. In order to produce a data set more mdica-
tive of the test group as a whole, a erages were calculated and 
used for statistical analysis. 
The values for ejection fraction for LCAD deficient 
mice were expected to be below nonoal during rest and after 
periods of endurance exercise when compared to the control 
group. Statistical analysi of the data showed that there was no 
significant difference in the values obtained within either group 
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as a result of exercise. It was also determined that there was no 
significant difference between the LCAD mice when compared 
to the control group. Ejection fraction aims to measure the vol-
ume change seen in the left ventricle during each contraction of 
the heart. As previously stated, this is done by comparing the 
volume of the left ventricle during diastole to the volume of the 
left ventricle during systole. The data provide relevant informa-
tion on the cardiac function ofLCAD mice. It was concluded 
that a single bout of endurance exercise has no effect on ejec-
tion fraction. in LCAD deficient mice. It can be deduced that 
the inability ofthese mice to use long-chain fatty acids during 
endurance exercise, a time when fatty acids are the primary 
fuel source, poses no detrimental effects to cardiac function 
during recovery. 
Data were also collected for fractional shortening in both 
LCAD and control groups. The means for both experimental 
groups before and after exercise compared favorably to the ex-
pected values presented in studies by both Gardin et a!. ( 1995) 
and Rottman et al. (2003). Because there was no significant 
difference between the values obtained for each experimental 
group as a result of exercise, it can be concluded that LCAD 
enzyme deficiency has no effect on cardiac function during 
recovery from exercise in LCAD deficient mice. There was 
a significant difference, however, in the fractional shortening 
values of the LCAD group when compared to the control group 
both before and after exercise. This finding is of particular in-
terest, especially because there was no significant difference in 
the ejection fraction values obtained from the two groups. The 
disparity present in the data could possibly point to some type 
of dysfunction in the cardiovascular system ofLCAD deficient 
mice. A more in-depth examination of fractional shortening in 
the LCAD mouse population would be necessary to develop 
further conclusions regarding the reason for the decreased 
fractional shortening values. 
Analysis of the cardiac output values collected from 
LCAD deficient mice before and after exercise showed that 
endurance exercise had no significant effect on cardiac output 
during recovery. This indicates that the inability ofLCAD mice 
to effectively metabolize fatty acids for use in cardiac muscle 
tissue during endurance exercise had no effect on overall car-
diac function after recovery. However, statistical analyses did 
reveal that cardiac output values obtained for the LCAD group 
were significantly lower than those of the control group. It is 
possible that this discrepancy can be explained by the fact that, 
in general, control mice are heavier than LCAD mice. Because 
this is true, control mice generally have bigger hearts and 
would, therefore, be expected to have greater overall cardiac 
output. Since heart size was not taken into account when calcu-
lating cardiac output, a one-way ANOVA was run analyzing the 
weights of both experimental groups; control mice were indeed 
significantly larger than LCAD mice (p<0.05). It can be reason-
ably assumed that, because the control mice are larger, they 
have larger hearts. This would adequately explain the differ-
ence seen in cardiac output measurements between the LCAD 
and control mouse experimental groups. It cannot be conclud-
ed, however, whether this was the true cause for discrepancy as 
heart weight was not taken for the two experimental groups. 
The data collected for both the LCAD and control groups 
were similar to those of Rottman et a!. (2003 ). This not only 
supports previous research on cardiac function in mice, it 
also further promotes the efficacy of echocardiography as an 
effective assessment technique for measuring cardiac output 
in mice. The determination of cardiac output via echocardio-
graphic methods is less intrusive than many of the other prac-
tices currently employed in the evaluation of cardiac function 
in mice. 
This research will contribute to the base of research sup-
porting echocardiography, although more is still needed in 
order for it to become a common tool for analysis of cardiac 
function in mice. While answers to specific questions regarding 
cardiac function in LCAD deficient mice have been addressed 
through this research, it has also raised some additional ques-
tions. Research should address whether the cardiac output 
would be affected if the mice were put through a training 
regimen rather than a single session of endurance exercise. 
Research should also examine whether the age of an LCAD de-
ficient mouse plays a role in cardiac function and whether car-
diac function ofLCAD deficient vs. normal mice would differ 
if readings were taken directly after exercise. Further, role of 
heart size in identified differences in CO data between LCAD 
and control mice could be investigated, along with determina-
tion of other physical or physiological reasons that LCAD mice 
appear to have decreased cardiac output when compared to 
control mice. 
Conclusion 
After extensively testing the contractile properties of 
the mouse heart via echocardiography, it was concluded that 
LCAD enzyme deficiency has no serious detrimental effects 
on cardiac function during recovery from exercise in LCAD 
deficient mice. It was also determined, however, that LCAD 
enzyme deficiency negatively affects cardiac function in LCAD 
deficient mice when compared to wild type control mice. 
LCAD deficient mice consistently displayed lower averages for 
both fractional shortening and cardiac output than control mice, 
which is indicative of decreased overall cardiac function. 
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Mentor Comments: 
In his mentor letter, Professor Charles Riggs points out that 
Evan Lord's work has implications for understanding how fatty 
oxidation disorders affect cardiac function. 
The work completed by Evan Lord is an extension of work done 
by previous students with my guidance. He received an Honors 
College Undergraduate Research grant in the Fa//2008 to 
begin work on his project. He completed the project in the 
Spring 2009. 
His work concentrated on the effects of fatty acid oxidation 
disorders and exercise on cardiac function using transthoracic 
echocardiography. While the technique has been used to eval-
uate the effects of a variety of conditions on the structure of the 
heart it has been used sparingly to evaluate cardiac function. 
Since one of the consequences of fatty acid oxidation disorders 
is frequently a decline in cardiac function, Mr. Lord decided 
to determine if echocardiography could be used to determine 
cardiac function in these mice and to determine if the disorder 
and the combination of the disorder and exercise would have 
an effect on function of the heart. 
It is clear that fatty oxidation disorders can have significant 
consequences for people of all ages. Little research has been 
done examining the effects of exercise on mice with these disor-
ders so his work will make valuable contributions to knowledge 
about the disease and also about the capabilities of affected 
animals to exercise. 
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